We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 905

Zogenix sues Massachusetts to overturn ban of opioid pain drug

  • Frommer Lawrence & Haug LLP
  • -
  • USA
  • -
  • April 14 2014

Zogenix, Inc., the San Diego-based manufacturer of the extended-release hydrocodone drug Zohydro ER, has sued the Governor of Massachusetts in U.S

Common sense contraceptive warnings cases

  • Reed Smith LLP
  • -
  • USA
  • -
  • April 4 2014

Even a casual reader of the blog would know that we like it when drug or device manufacturers defeat dubious claims. It is also no secret that we are

Fourth Circuit upholds dismissal of FCA claims against pharmaceutical services provider

  • Arnold & Porter LLP
  • -
  • USA
  • -
  • April 3 2014

In United States ex rel. Rostholder v. Omnicare, Inc., --- F.3d ---, No. 12-2431, 2014 WL 661351 (4th Cir. Feb. 21, 2014), the United States Court of

Fifth Circuit affirms preemption of claims against generic manufacturers and rejects innovator liability

  • Arnold & Porter LLP
  • -
  • USA
  • -
  • April 3 2014

In Lashley v. Pfizer, Inc., 2014 WL 661058 (5th Cir. Feb. 21, 2014), the United States Court of Appeals for the Fifth Circuit held that federal law

Proposition 65 actions dismissed for failure to comply with pre-suit notice requirements

  • Arnold & Porter LLP
  • -
  • USA
  • -
  • April 3 2014

In Physicians Committee for Responsible Medicine v. McDonald's Corporation, 224 Cal. App 4th 166 (Feb. 27, 2014) (PCRM), the California Court of

Arkansas Supreme Court reverses US$1.2 billion Risperdal verdict

  • Arnold & Porter LLP
  • -
  • USA
  • -
  • April 3 2014

In Ortho-McNeil-Janssen Pharm., Inc. v. State, ---S.W.3d---, 2014 Ark. 124 (2014), the Arkansas Supreme Court reversed a US$1.2 billion jury verdict

The more things change, the more they remain the same

  • Reed Smith LLP
  • -
  • USA
  • -
  • April 3 2014

Not too long ago (March 28, and April 2) we read with interest a couple of articles on 360 that brought back unpleasant memories. The articles

Litigation holds matter

  • Reed Smith LLP
  • -
  • USA
  • -
  • April 3 2014

This post discusses litigation holds. Litigation holds aren't sexy. They aren't going to take counsel to the Supreme Court. They aren't going to make

Government seeks to limit First Amendment application to False Claims Act under Caronia

  • Saul Ewing LLP
  • -
  • USA
  • -
  • March 28 2014

Off-label prescriptions are common among physicians, occurring between 15 percent and 50 percent of the time for any given drug. However, under the

Fosamax preemption ruling extended to other MDL cases

  • Reed Smith LLP
  • -
  • USA
  • -
  • March 26 2014

Last July we discussed a rare event, a preemption win for an innovator drug under the Wyeth v. Levine, 555 U.S. 555 (2009), "clear evidence" standard